{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:19:41Z","timestamp":1793992781995,"version":"4.8.0"},"reference-count":45,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of \u201cappropriateness\u201d\u2014the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. Methods: A retrospective descriptive study was conducted using data from the 2023\u20132024 and 2024\u20132025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals \u2265 65 years, adults 60\u201364 years, adults 18\u201359 years (with\/without chronic conditions), children, and pregnant\/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60\u201364 age group as a reference. Analyses were performed with Stata 18.0. Results: In 2023\u20132024, 78.8% of individuals \u2265 65 received recommended vaccines, compared to 100% in the 60\u201364 group (RR = 0.23; 95% CI: 0.225\u20130.231). Adults 18\u201359, children, and pregnant\/postpartum women showed \u226599% adherence. In 2024\u20132025, appropriateness in the \u226565 group improved to 96.1% (RR = 0.12; 95% CI: 0.118\u20130.128). All other groups maintained high adherence (\u226599%), except for 6.2% of children aged 6 months\u20132 years who inappropriately received LAIV. Conclusions: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children\u2014highlights the need for targeted interventions to ensure complete patient safety.<\/jats:p>","DOI":"10.3390\/vaccines13090925","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T16:05:22Z","timestamp":1756829122000},"page":"925","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influenza Vaccination Appropriateness: Insights from the Local Health Unit of Catania During the 2023\/2024 and 2024\/2025 Seasons"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2031-0449","authenticated-orcid":false,"given":"Francesco","family":"Leonforte","sequence":"first","affiliation":[{"name":"Department of Integrated Hygiene, Organizational, and Service Activities (Structural Department), Health Management, University Hospital Polyclinic \u201cG. Rodolico\u2014San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-1103","authenticated-orcid":false,"given":"Claudio","family":"Fiorilla","sequence":"additional","affiliation":[{"name":"Department of Public Health, Syracuse Local Health Authority, 96100 Siracusa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Giorgianni","sequence":"additional","affiliation":[{"name":"Public Health Unit, Epidemiology and Preventive Medicine (SEMP), Provincial Health Authority of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1348-6438","authenticated-orcid":false,"given":"Vito","family":"Nicosia","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, University of Catania, 95131 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Contarino","sequence":"additional","affiliation":[{"name":"Department of Public Health, Syracuse Local Health Authority, 96100 Siracusa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-1030","authenticated-orcid":false,"given":"Cristina","family":"Genovese","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0251-8144","authenticated-orcid":false,"given":"Giovanni","family":"Genovese","sequence":"additional","affiliation":[{"name":"Translational Molecular Medicine and Surgery, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-6245","authenticated-orcid":false,"given":"Giustino","family":"Morlino","sequence":"additional","affiliation":[{"name":"Accreditation and Supply Network Area, Local Health Authority \u201cRoma 1\u201d, 00193 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-303X","authenticated-orcid":false,"given":"Martina","family":"Chimienti","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome \u201cTor Vergata\u201d and District and Commissioning Management, Local Health Authority \u201cRoma 2\u201d, 00133 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mistretta","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, University of Catania, 95131 Catania, Italy"},{"name":"Scientific Communication Service, National Institute of Public Health (Istituto Superiore di Sanit\u00e0), 00161 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A Brief Review of Influenza Virus Infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jmwh.13203","article-title":"Influenza and Influenza Vaccine: A Review","volume":"66","author":"Nypaver","year":"2021","journal-title":"J. Midwifery Womens Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a038356","DOI":"10.1101\/cshperspect.a038356","article-title":"Human Influenza Epidemiology","volume":"11","author":"Ryu","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and Antiviral Resistance: An Overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2243","DOI":"10.1002\/rmv.2243","article-title":"Influenza Vaccines: Past, Present, and Future","volume":"32","author":"Kim","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, J., Chen, Y., Wang, X., and Yu, H. (2021). Influenza-Associated Disease Burden in Mainland China: A Systematic Review and Meta-Analysis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-82161-z"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00040-22","DOI":"10.1128\/cmr.00040-22","article-title":"Antiviral Approaches against Influenza Virus","volume":"36","author":"Kumari","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Smyk, J., Szyd\u0142owska, N., Szulc, W., and Majewska, A. (2022). Evolution of Influenza Viruses\u2014Drug Resistance, Treatment Options, and Prospects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012244"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101124","DOI":"10.1016\/j.arr.2020.101124","article-title":"Effects of Influenza Vaccination on the Risk of Cardiovascular and Respiratory Diseases and All-Cause Mortality","volume":"62","author":"Cheng","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nuwarda, R.F., Alharbi, A.A., and Kayser, V. (2021). An Overview of Influenza Viruses and Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9091032"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajic.2023.11.009","article-title":"Influenza Vaccination Mitigates Severe Complications in Hospitalized Patients: A Ten-Year Observational Study, Spain, 2009\u20132019","volume":"52","author":"Carpio","year":"2024","journal-title":"Am. J. Infect. Control"},{"key":"ref_12","unstructured":"Ministero Della Salute (2025, March 06). Prevenzione e Controllo Dell\u2019influenza: Raccomandazioni per La Stagione 2024\u20132025. Available online: https:\/\/www.epicentro.iss.it\/influenza\/raccomandazioni-ministero."},{"key":"ref_13","first-page":"E1","article-title":"Il Nuovo Vaccino Coniugato Antipneumococcico 15-Valente per La Prevenzione Delle Infezioni Da S. Pneumoniae in Et\u00e0 Pediatrica: Una Valutazione Di HTA","volume":"64","author":"Vitale","year":"2023","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Trombetta, C.M., Kistner, O., Montomoli, E., Viviani, S., and Marchi, S. (2022). Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines. Vaccines, 10.","DOI":"10.3390\/vaccines10050714"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Almadhoon, H., Hamdallah, A., Elsayed, S., Hagrass, A., Hasan, M., Fayoud, A., Al-Kafarna, M., Elbahnasawy, M., Alqatati, F., and Ragab, K. (2022). The Effect of Influenza Vaccine in Reducing the Severity of Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-18618-6"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Boccalini, S., de Waure, C., Martorella, L., Orlando, P., Bonanni, P., and Bechini, A. (2025). The Evolution of Annual Immunization Recommendations Against Influenza in Italy: The Path to Precision Vaccination. Vaccines, 13.","DOI":"10.3390\/vaccines13040356"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107202","DOI":"10.1016\/j.ijid.2024.107202","article-title":"Influenza Epidemiology and Vaccine Effectiveness during the 2023\/2024 Season in Italy: A Test-Negative Case-Control Study","volume":"147","author":"Domnich","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11739-023-03456-9","article-title":"Influenza Vaccination for Elderly, Vulnerable and High-Risk Subjects: A Narrative Review and Expert Opinion","volume":"19","author":"Consoli","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/21645515.2020.1810494","article-title":"Lowering the Recommended Age for the Free and Active Offer of Influenza Vaccination in Italy: Clinical and Economic Impact Analysis in the Liguria Region","volume":"17","author":"Trucchi","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/21645515.2017.1388480","article-title":"The Appropriateness of the Use of Influenza Vaccines: Recommendations from the Latest Seasons in Italy","volume":"14","author":"Bonanni","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pestarino, L., Domnich, A., Orsi, A., Bianchi, F., Cannavino, E., Brasesco, P.C., Russo, G., Valbonesi, S., Vallini, G., and Ogliastro, M. (2023). Rollout of the 2022\/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults. Vaccines, 11.","DOI":"10.3390\/vaccines11121748"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijid.2020.02.040","article-title":"Who and When to Vaccinate against Influenza","volume":"93","author":"Buchy","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_23","first-page":"1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2022-23 Influenza Season","volume":"71","author":"Walensky","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e29000","DOI":"10.1002\/jmv.29000","article-title":"Rotavirus Vaccination as a Public Health Strategy to Reduce the Burden of Hospitalization: The Field Experience of Italy (2008\u20132018)","volume":"95","author":"Amodio","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Calabr\u00f2, G.E., Boccalini, S., Panatto, D., Rizzo, C., Di Pietro, M.L., Abreha, F.M., Ajelli, M., Amicizia, D., Bechini, A., and Giacchetta, I. (2022). The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19074166"},{"key":"ref_27","unstructured":"Italian Medicines Agency (AIFA) (2025, August 27). AIFA: Influenza Vaccines for the 2024\u20132025 Season. AIFA, 16 September 2024, Available online: https:\/\/www.aifa.gov.it\/en\/-\/influenza_8_i_vaccini_autorizzati_per_la_stagione_2024-2025."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Soni, D., Van Haren, S., Idoko, O., Evans, J., Diray-Arce, J., Dowling, D., and Levy, O. (2020). Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.590373"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.vaccine.2018.12.057","article-title":"Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy","volume":"37","author":"Boccalini","year":"2019","journal-title":"Vaccine"},{"key":"ref_30","first-page":"105","article-title":"Analisi di costo-efficacia e budget impact per il vaccino antinfluenzale quadrivalente ad alto dosaggio nella popolazione anziana Italiana","volume":"8","author":"Rumi","year":"2021","journal-title":"Glob. Reg. Health Technol. Assess."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Domnich, A., Lapi, F., Orsi, A., Grattagliano, I., Rossi, A., and Cricelli, C. (2024). Declining number of general practitioners can impair influenza vaccination uptake among Italian older adults: Results from a panel analysis. BMC Health Serv. Res., 24.","DOI":"10.1186\/s12913-024-11443-9"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Schmid, P., Rauber, D., Betsch, C., Lidolt, G., and Denker, M.L. (2017). Barriers of Influenza Vaccination Intention and Behavior\u2014A Systematic Review of Influenza Vaccine Hesitancy, 2005\u20132016. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170550"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/14760584.2025.2499728","article-title":"Enhanced influenza vaccination for older adults in Europe: A review of the current situation and expert recommendations for the future","volume":"24","author":"Gavazzi","year":"2025","journal-title":"Expert Rev. Vaccines"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100327","DOI":"10.1016\/j.jvacx.2023.100327","article-title":"High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update","volume":"14","author":"Lee","year":"2023","journal-title":"Vaccine X"},{"key":"ref_35","unstructured":"Italian Ministry of Health (2025, August 27). Circular of April 21, 2023\u2014Prevention and Control of Influenza: Recommendations for the 2023\u20132024Season. (21-04-2023), Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2023&codLeg=93294&parte=1%20&serie=null."},{"key":"ref_36","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2024). Seasonal Influenza\u2014Annual Epidemiological Report for 2023\/2024."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e058705","DOI":"10.1136\/bmjopen-2021-058705","article-title":"Factors Influencing Influenza, Pneumococcal and Shingles Vaccine Uptake and Refusal in Older Adults: A Population-Based Cross-Sectional Study in England","volume":"13","author":"Tan","year":"2023","journal-title":"BMJ Open"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Han, K., Hou, Z., Tu, S., Liu, M., Chantler, T., and Larson, H. (2024). Factors Influencing Childhood Influenza Vaccination: A Systematic Review. Vaccines, 12.","DOI":"10.3390\/vaccines12030233"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmjebm-2023-112767","article-title":"Trivalent and Quadrivalent Seasonal Influenza Vaccine in Adults Aged 60 and Older: A Systematic Review and Network Meta-Analysis","volume":"29","author":"Veroniki","year":"2024","journal-title":"BMJ Evid. Based Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of Vaccine Administration Modality on Immunogenicity and Efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2019.11.078","article-title":"Prevalence and Types of Vaccination Errors from 2009 to 2018: A Systematic Review of the Medical Literature","volume":"38","author":"Hart","year":"2020","journal-title":"Vaccine"},{"key":"ref_42","first-page":"358","article-title":"Exploring Tdap and Influenza Vaccine Uptake and Its Determinants in Pregnancy: A Cross-Sectional Study","volume":"34","author":"Brillo","year":"2022","journal-title":"Ann. Ig."},{"key":"ref_43","unstructured":"Italian Ministry of Health (2025, August 27). Circular of May 21, 2024\u2014Prevention and Control of Influenza: Recommendations for the 2024\u20132025 Season. (20-05-2024), Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2024&codLeg=100738&parte=1%20&serie=null."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100483","DOI":"10.1016\/j.jvacx.2024.100483","article-title":"Vaccination Coverage during Pregnancy and Factors Associated with Refusal of Recommended Vaccinations: An Italian Cross Sectional Study","volume":"18","author":"Seravalli","year":"2024","journal-title":"Vaccine X"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Filia, A., Bella, A., D\u2019Ancona, F., Fabiani, M., Giambi, C., Rizzo, C., Ferrara, L., Pascucci, M.G., and Rota, M.C. (2019). Childhood Vaccinations: Knowledge, Attitudes and Practices of Paediatricians and Factors Associated with Their Confidence in Addressing Parental Concerns, Italy, 2016. Eurosurveillance, 24.","DOI":"10.2807\/1560-7917.ES.2019.24.6.1800275"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/925\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:55Z","timestamp":1760034955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["vaccines13090925"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13090925","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}